Cargando…

Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden

Interpretation of serological findings in suspected Lyme borreliosis (LB) is challenging and IgM reactivities may have low predictive value. Therefore, if used indiscriminately, there is a risk for incorrect diagnosis of LB. To evaluate the usefulness of IgM titer determination, we performed a study...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xijia, Tabibzada, Nazanin, Lindgren, Helena, Sjöstedt, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350645/
https://www.ncbi.nlm.nih.gov/pubmed/37465761
http://dx.doi.org/10.3389/fcimb.2023.1192038
_version_ 1785074178431385600
author Liu, Xijia
Tabibzada, Nazanin
Lindgren, Helena
Sjöstedt, Anders
author_facet Liu, Xijia
Tabibzada, Nazanin
Lindgren, Helena
Sjöstedt, Anders
author_sort Liu, Xijia
collection PubMed
description Interpretation of serological findings in suspected Lyme borreliosis (LB) is challenging and IgM reactivities may have low predictive value. Therefore, if used indiscriminately, there is a risk for incorrect diagnosis of LB. To evaluate the usefulness of IgM titer determination, we performed a study of the prevalence of Borrelia-specific antibodies in serological samples from patients with suspected LB analyzed during the period 2010 - 2021 at the University Hospital of Umeå in Sweden. In total, 19,335 samples had been analyzed for the presence of IgG and IgM antibodies. Overall, there were higher percentages of IgM positive or borderline titers, 1,847 (9.6%) and 905 (4.7%), respectively, than IgG positive or borderline titers, 959 (5.0%) and 406 (2.1%), respectively. Peak number of samples were recorded 2012 - 2013, exceeding 1,800, whereas there were around 1,200 during 2020 - 2021. The peak number of positive IgG and/or positive IgM samples were observed during the period 2015 - 2017 with close to, or above 400, and concomitantly, the proportion of IgG positive samples increased markedly. For IgG positive samples, the increase followed a positive linear time trend (P< 0.001). Peak monthly numbers were observed during August, September, and October. This seasonal increase was significant for the IgG positive group (P< 0.05), but not for the IgM positive/IgG negative group. Repeated samples were obtained from 3,188 individuals and of the initial samples 2,817 were (88%) IgG negative and 2,315 (72%) were IgM negative and of these, 130 (4%) showed IgG seroconversion and 300 (9%) IgM seroconversion. Collectively, the data demonstrate that IgG and/or IgM positive samples represented a minority of all samples, even when repeated sampling had occurred, and IgM positive samples were much more common than IgG positive samples. Thus, the accuracy of the clinical suspicion was low and this will lead to a low predictive value of the analysis, in particular of IgM. These findings question the use of IgM titer determination as a routine analysis.
format Online
Article
Text
id pubmed-10350645
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103506452023-07-18 Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden Liu, Xijia Tabibzada, Nazanin Lindgren, Helena Sjöstedt, Anders Front Cell Infect Microbiol Cellular and Infection Microbiology Interpretation of serological findings in suspected Lyme borreliosis (LB) is challenging and IgM reactivities may have low predictive value. Therefore, if used indiscriminately, there is a risk for incorrect diagnosis of LB. To evaluate the usefulness of IgM titer determination, we performed a study of the prevalence of Borrelia-specific antibodies in serological samples from patients with suspected LB analyzed during the period 2010 - 2021 at the University Hospital of Umeå in Sweden. In total, 19,335 samples had been analyzed for the presence of IgG and IgM antibodies. Overall, there were higher percentages of IgM positive or borderline titers, 1,847 (9.6%) and 905 (4.7%), respectively, than IgG positive or borderline titers, 959 (5.0%) and 406 (2.1%), respectively. Peak number of samples were recorded 2012 - 2013, exceeding 1,800, whereas there were around 1,200 during 2020 - 2021. The peak number of positive IgG and/or positive IgM samples were observed during the period 2015 - 2017 with close to, or above 400, and concomitantly, the proportion of IgG positive samples increased markedly. For IgG positive samples, the increase followed a positive linear time trend (P< 0.001). Peak monthly numbers were observed during August, September, and October. This seasonal increase was significant for the IgG positive group (P< 0.05), but not for the IgM positive/IgG negative group. Repeated samples were obtained from 3,188 individuals and of the initial samples 2,817 were (88%) IgG negative and 2,315 (72%) were IgM negative and of these, 130 (4%) showed IgG seroconversion and 300 (9%) IgM seroconversion. Collectively, the data demonstrate that IgG and/or IgM positive samples represented a minority of all samples, even when repeated sampling had occurred, and IgM positive samples were much more common than IgG positive samples. Thus, the accuracy of the clinical suspicion was low and this will lead to a low predictive value of the analysis, in particular of IgM. These findings question the use of IgM titer determination as a routine analysis. Frontiers Media S.A. 2023-07-03 /pmc/articles/PMC10350645/ /pubmed/37465761 http://dx.doi.org/10.3389/fcimb.2023.1192038 Text en Copyright © 2023 Liu, Tabibzada, Lindgren and Sjöstedt https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Liu, Xijia
Tabibzada, Nazanin
Lindgren, Helena
Sjöstedt, Anders
Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden
title Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden
title_full Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden
title_fullStr Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden
title_full_unstemmed Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden
title_short Utility of Borrelia-specific IgM and IgG antibody titer determinations during a 12-year period – results from a clinical laboratory in Northern Sweden
title_sort utility of borrelia-specific igm and igg antibody titer determinations during a 12-year period – results from a clinical laboratory in northern sweden
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350645/
https://www.ncbi.nlm.nih.gov/pubmed/37465761
http://dx.doi.org/10.3389/fcimb.2023.1192038
work_keys_str_mv AT liuxijia utilityofborreliaspecificigmandiggantibodytiterdeterminationsduringa12yearperiodresultsfromaclinicallaboratoryinnorthernsweden
AT tabibzadanazanin utilityofborreliaspecificigmandiggantibodytiterdeterminationsduringa12yearperiodresultsfromaclinicallaboratoryinnorthernsweden
AT lindgrenhelena utilityofborreliaspecificigmandiggantibodytiterdeterminationsduringa12yearperiodresultsfromaclinicallaboratoryinnorthernsweden
AT sjostedtanders utilityofborreliaspecificigmandiggantibodytiterdeterminationsduringa12yearperiodresultsfromaclinicallaboratoryinnorthernsweden